QurieGen
Precision Medicine via Single-Cell AI
Netherlands · $2.4M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- quriegen.com
- Total Funding
- $2.4M
- Last Round
- $2.4M Pre-SeedApr 2025
- Rounds
- 1
About
Dutch techbio company using single-cell AI and multi-omics data to build cell navigation models for drug discovery and development.
Summary
QurieGen is an Artificial Intelligence company based in Netherlands. It has raised $2.4M in total across 1 round, most recently a $2.4M Pre-Seed round in Apr 2025. Investors include Tensor Ventures, Lighthouse Ventures and Tim Draper.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2025
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...